Navigation Links
Mithridion raises $1.6M through angel networks

Madison, Wis. Mithridion, the University of Wisconsin-Madison spinoff developing a drug for people with Alzheimer's disease, has closed its first round of financing with $1.6 million, of which it has received the first portion, that will go toward buying lab equipment, hiring scientists and developing drug candidates.

Trevor Twose, Mithridion's ......

Full article >>> als are successful Mithridion will partner or sell to a large pharmaceutical company in stage two or three trials. By that time, its technology will be reasonably proven enough, at least, for a large pharma to take on the final testing and marketing.

Mithridion's product is based on research by Jeff Johnson,......

Full article >>>
'"/>

Source:wistechnology.com By Jason Stitt 02/01/06


Related biology technology :

1. Mithridion wins grants for Alzheimers research
2. Digital Healthcare Conference, Mithridion, lack of degrees
3. Madison-based Mithridion seeks to capitalize on Alzheimers breakthrough
4. TomoTherapy raises $223 million in IPO
5. Fusion 2007: CA chief says IT complexity raises risk
6. Inline intellectual property raises legal issues
7. Biotech with Madison ties raises $21M in capital
8. ConjuGon raises $3.3 million to fund clinical trials
9. Nerites raises $1 million to improve medical tech
10. Brady Corp. raises $137 million in public offering
11. aOva Technologies raises $3 million
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... The Fight Against Cancer Innovation Trust (FACIT) and the ... report that Fusion Pharmaceuticals Inc. (Fusion) has closed a ... – JJDC, Inc. (JJDC) as the lead investor. Additional, ... and Genesys Capital, as well as founding investor FACIT.  ... ...
(Date:2/23/2017)... , Feb. 23, 2017  In Atlanta, it seems ... fashion, and culture intertwine to create an expressive and dynamic ... reflect this energy and contribute to it. ... Hair Fairies seeks to carry on that tradition ... Atlanta salon is the newest of ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life ... product line of oncolytic vaccinia viruses for virotherapy ... as part of Genelux,s proprietary, vaccinia virus-based technology ... excited to enter into a partnership with Genelux ... oncolytic vaccinia viruses for use in research," said ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... of multiple immunoassay-based threat detection technologies by researchers from the Pacific National ... threat detection technology was found to have the best level of detection ...
Breaking Biology Technology:
(Date:2/7/2017)... 7, 2017   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... innovative, highly flexible and award winning eClinical solution, is ... iMedNet is a proven Software-as-a-Service (SaaS) clinical research ... (EDC), but also delivers an entire suite of eClinical ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute ... Larry Schlesinger as the Institute,s new President ... Biomed effective May 31, 2017. He is currently the Chair ... of the Center for Microbial Interface Biology at Ohio State ... as the new President and CEO of Texas Biomed," said ...
(Date:2/2/2017)... 2017  Central to its deep commitment to ... The Japan Prize Foundation today announced the laureates ... the envelope in their respective fields of Life ... are being recognized with the 2017 Japan Prize ... contribute to the advancement of science and technology, ...
Breaking Biology News(10 mins):